Skip to main content

Table 2 Baseline of outcome measure

From: Synergistic efficacy of repetitive peripheral magnetic stimulation on central intermittent theta burst stimulation for upper limb function in patients with stroke: a double-blinded, randomized controlled trial

 

rPMS + iTBS

Sham rPMS + iTBS

p-value

FMA-UE

28.6 ± 21.3

33.4 ± 19.7

0.542

FIM-Self care

4.2 ± 1.6

4.7 ± 1.4

0.407

ARAT

19.1 ± 20.9

21.8 ± 23.8

0.758

 ARAT-GM

4.1 ± 2.9

5.0 ± 3.9

0.484

 ARAT-Grasp

6.0 ± 7.3

6.6 ± 7.9

0.825

 ARAT-Grip

4.3 ± 4.8

4.8 ± 5.6

0.801

 ARAT-Pinch

4.8 ± 7.1

5.4 ± 7.6

0.838

SIS

53.2 ± 11.0

58.9 ± 14.7

0.252

 SIS-S1

29.0 ± 13.8

33.0 ± 14.0

0.450

 SIS-S2

82.7 ± 16.3

85.5 ± 19.0

0.678

 SIS-S3

52.6 ± 12.0

55.0 ± 11.2

0.593

 SIS-S4

83.4 ± 27.8

95.2 ± 7.9

0.150

 SIS-S5

51.3 ± 12.2

54.6 ± 26.0

0.664

 SIS-S6

50.2 ± 25.6

57.7 ± 30.7

0.487

 SIS-S7

23.9 ± 27.8

26.4 ± 35.6

0.838

 SIS-S8

37.7 ± 21.2

48.4 ± 19.8

0.179

  1. Data are presented as mean ± standard deviation; ARAT: Action Research Arm Test; GM: Gross motor; FIM: Functional Independence Measure; FMA-UE: Fugl-Meyer Assessment-Upper Extremity; SIS: Stroke Impact Scale, S1: Strength; S2: Memory and Thinking; S3: Emotion; S4: Communication; S5: Activity of Daily Living; S6: Mobility; S7: Hand Function; S8: Participation